Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ditchdigger who wrote (57110)	4/5/2016 9:13:08 AM
From: E_K_S	Read Replies (2) of 78666

Tekla Healthcare Opportunities Fund (THQ) - A small add for me to this CEF Drug/Pharma fund (selling 10% below NAV) THQ fund pays a monthly dividend made up of capital gains and div income. They also use 20% leverage (still small for a CEF fund). The fund is made up of good Parma/Drug dividend payers and then other more risky Bio-tech companies. The fund is rather new only w/ about an 18 month track record. The company announced they would be buying back 12% of shares thru 6/2016 too. I have about a 2% portfolio position in the fund w/ three different Buys all in th $16.00/share price range. EKS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next